Imagion Biosystems announces an amendment to the previously announced close date. For the purposes of the Pro-Rata Renewable Rights Issue, the indicative close date is Friday, 15 November 2019.
Read the amendment.
The Stock Network Interview – Opening US trial sites for MagSense® breast cancer imaging
October 17, 2026
Lel Smits from The Stock Network sat down with Imagion Biosystems’ Bob Proulx to discuss how MagSense® looks to improve upon today’s imaging, what the